Skip Navigation

JNCI Journal of the National Cancer Institute 1994 86(4):252-255; doi:10.1093/jnci/86.4.252
© 1994 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ross, R. K.
Right arrow Articles by Henderson, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, R. K.
Right arrow Articles by Henderson, B. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Do Diet and Androgens Alter Prostate Cancer Risk via a Common Etiologic Pathway?

Ronald K. Ross and Brian E. Henderson

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Article topics:

  • Medicine..Prostate
  • Oncology..Environmental/Lifestyle Causes of Prostate Cancer
  • Oncology..Diet and Nutrition
  • Oncology..Treatment Options for Prostate Cancer
  • Medicine..Epidemiology, Causes, and Risks of Prostate Cancer
  • Oncology..Prostate Cancer
  • Oncology..Tobacco and Smoking
  • Biochemistry..Fats
  • Oncology..Sun Exposure
  • Oncology..Patient Factors
  • Medicine..Pediatric Nutrition
  • Oncology..Incidence and Mortality of Prostate Cancer
  • Oncology..Surgery
  • Oncology..Dietary Fats
  • Oncology..Environmental/Lifestyle Causes of Breast Cancer
  • Oncology..Environmental/Lifestyle Causes of Colorectal Cancer
  • Medicine..Pediatric Smoking
  • Oncology..Aging and Cancer
  • Medicine..Diet
  • Oncology..Treatment Options for Breast Cancer
  • Oncology..Treatment Options for Colorectal Cancer
  • Oncology..Epidemiology
  • Oncology..Epidemiology, Causes, and Risk Factors of Breast Cancer
  • Oncology..Epidemiology, Causes, and Risk Factors of Colorectal Cancer
  • Oncology..Childhood Cancers

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Cnattingius, F. Lundberg, S. Sandin, H. Gronberg, and A. Iliadou
Birth Characteristics and Risk of Prostate Cancer: the Contribution of Genetic Factors
Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2422 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Kurahashi, M. Inoue, M. Iwasaki, S. Sasazuki, a. S. Tsugane, and for the Japan Public Health Center-Based Prospecti
Dairy Product, Saturated Fatty Acid, and Calcium Intake and Prostate Cancer in a Prospective Cohort of Japanese Men
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 930 - 937.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. V. Singh, S. Choi, Y. Zeng, E.-R. Hahm, and D. Xiao
Guggulsterone-Induced Apoptosis in Human Prostate Cancer Cells Is Caused by Reactive Oxygen Intermediate Dependent Activation of c-Jun NH2-Terminal Kinase
Cancer Res., August 1, 2007; 67(15): 7439 - 7449.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Xiao, K. L. Lew, Y.-A. Kim, Y. Zeng, E.-R. Hahm, R. Dhir, and S. V. Singh
Diallyl Trisulfide Suppresses Growth of PC-3 Human Prostate Cancer Xenograft In vivo in Association with Bax and Bak Induction.
Clin. Cancer Res., November 15, 2006; 12(22): 6836 - 6843.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. V. Singh, Y. Zeng, D. Xiao, V. G. Vogel, J. B. Nelson, R. Dhir, and Y. B. Tripathi
Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak
Mol. Cancer Ther., November 1, 2005; 4(11): 1747 - 1754.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. P.A. Zeegers, M. J.M. Dirx, and P. A. van den Brandt
Physical Activity and the Risk of Prostate Cancer in The Netherlands Cohort Study, Results after 9.3 Years of Follow-up
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1490 - 1495.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wang, D. H. Catlin, B. Starcevic, D. Heber, C. Ambler, N. Berman, G. Lucas, A. Leung, K. Schramm, P. W. N. Lee, et al.
Low-Fat High-Fiber Diet Decreased Serum and Urine Androgens in Men
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3550 - 3559.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
W. H James
A hypothesis on the sexual behaviour of men who are destined to develop prostate cancer
Int. J. Epidemiol., April 1, 2005; 34(2): 483 - 485.
[Full Text] [PDF]


Home page
Endocr Relat CancerHome page
Y. Nakamura, T. Suzuki, M. Nakabayashi, M. Endoh, K. Sakamoto, Y. Mikami, T. Moriya, A. Ito, S. Takahashi, S. Yamada, et al.
In situ androgen producing enzymes in human prostate cancer
Endocr. Relat. Cancer, March 1, 2005; 12(1): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. L. Dillingham, B. L. McVeigh, J. W. Lampe, and A. M. Duncan
Soy Protein Isolates of Varying Isoflavone Content Exert Minor Effects on Serum Reproductive Hormones in Healthy Young Men
J. Nutr., March 1, 2005; 135(3): 584 - 591.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. L. Amling, R. H. Riffenburgh, L. Sun, J. W. Moul, R. S. Lance, L. Kusuda, W. J. Sexton, D. W. Soderdahl, T. F. Donahue, J. P. Foley, et al.
Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy
J. Clin. Oncol., February 1, 2004; 22(3): 439 - 445.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. El-Bayoumy, J. P. Richie Jr., T. Boyiri, D. Komninou, B. Prokopczyk, N. Trushin, W. Kleinman, J. Cox, B. Pittman, and S. Colosimo
Influence of Selenium-enriched Yeast Supplementation on Biomarkers of Oxidative Damage and Hormone Status in Healthy Adult Males: A Clinical Pilot Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1459 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Venkateswaran, L. H. Klotz, and N. E. Fleshner
Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines
Cancer Res., May 1, 2002; 62(9): 2540 - 2545.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Heber
Prostate enlargement: the canary in the coal mine?
Am. J. Clinical Nutrition, April 1, 2002; 75(4): 605 - 606.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. J. M. Dirx, P. A. van den Brandt, R. A. Goldbohm, and L. H. Lumey
Energy Restriction in Childhood and Adolescence and Risk of Prostate Cancer: Results from the Netherlands Cohort Study
Am. J. Epidemiol., September 15, 2001; 154(6): 530 - 537.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Zi, R. P. Singh, and R. Agarwal
Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells
Carcinogenesis, December 1, 2000; 21(12): 2225 - 2235.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
M. C. Bosland
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Ekbom, J. Wuu, H.-O. Adami, C.-M. Lu, P. Lagiou, D. Trichopoulos, and C.-c. Hsieh
Duration of Gestation and Prostate Cancer Risk in Offspring
Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 221 - 223.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
C. Lopez-Otin and E. P. Diamandis
Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
Endocr. Rev., August 1, 1998; 19(4): 365 - 396.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
R. Santti, S. Makela, L. Strauss, J. Korkman, and M.-L. Kostian
Phytoestrogens: Potential Endocrine Disruptors in Males
Toxicology and Industrial Health, January 1, 1998; 14(1-2): 223 - 237.
[Abstract] [PDF]


This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ross, R. K.
Right arrow Articles by Henderson, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, R. K.
Right arrow Articles by Henderson, B. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?